Celebrating the founding of Sanofi's future Evolutive Vaccines Facility (EVF) production unit (L-R): CEO Paul Hudson; Olivier Véran, Minister of Health; Frédérique Vidal, Minister of Higher Education, Research and Innovation; Jean Castex, Prime Minister; Agnès Pannier-Runacher, Minister of Industry; Eric Bellot, Mayor of Neuville-sur-Saône (courtesy Sanofi)
March 8, 2022 01:30 PM ESTUpdated 03:25 PM
Pharma
Manufacturing

Sanofi CEO Paul Hud­son sketch­es a $1B-plus in­vest­ment on its new mR­NA cen­ter

John Carroll

Editor & Founder

Over the years, Paris-based Sanofi has had a com­plex re­la­tion­ship with its home coun­try of France. One for­mer CEO (Chris Viehbach­er) seemed to en­joy prod­ding …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Among phar­ma CEOs, the IRA now and the IRA lat­er get very dif­fer­ent re­ac­tions

Bris­tol My­ers restarts ra­dio­phar­ma­ceu­ti­cal Phase 3 tri­al, but de­lays read­out by one year

An­drew Left, short sell­er who cam­paigned against Valeant, is ac­cused of fraud by SEC

Up­dat­ed: With cost-cut­ting un­der­way, Bris­tol My­ers rais­es guid­ance, touts Phase 3 win and scraps an­oth­er

Com­pound­ed weight loss drugs have re­sult­ed in mis­dos­ing, hos­pi­tal­iza­tions, FDA warns

sponsored

Crit­i­cal Junc­tures in Gene Ther­a­py Clin­i­cal Ma­te­r­i­al Man­u­fac­tur­ing: Where Do I Start? And Will It Work?

A service from the Financial Times